Underdosing apixaban ups risk of all-cause mortality
Underdosing of direct oral anticoagulants (DOACs) does not reduce the risk of bleeding, systemic embolization, or all-cause mortality in patients with atrial fibrillation (AF), reveals a study. In particular, inappropriate underdosing with apixaban results in increased all-cause mortality.
